Please try another search
Hunan Er-Kang Pharmaceutical Co., Ltd manufactures and sells APIs, finished drug products, and pharmaceutical excipients in China and internationally. Its APIs include glycerin, dilute hydrochloric acid, sulbenicillin sodium, dihydroxypropyl theophylline, calamine powder, sulfadiazine, sulphaguanidine, TMP, and resorcinol. The company’s finished drugs primarily comprise sulbenicillin sodium for injection and compound liquorice tablets. Its conventional pharmaceutical excipients include pharmaceutical glycerin, medicinal ethanol, medicinal propylene glycol, medicinal sodium hydroxide, and sucrose; and new pharmaceutical excipients comprise hydroxypropyl starch empty capsules, hydroxypropyl starch soft capsules, and citrate and its series products. Hunan Er-Kang Pharmaceutical Co., Ltd was founded in 2003 and is based in Changsha, China.
Name | Age | Since | Title |
---|---|---|---|
Fangwen Shuai | 57 | - | Chairman |
Zhao Xun | 35 | 2019 | CFO & Non Independent Director |
Junwen Wang | 60 | 2019 | Independent Director |
Qingrong Sun | 37 | 2019 | GM & Non-Independent Director |
Qing Peng | 52 | - | Chairman of Supervisory Board |
Xue Tan | - | 2022 | Independent Director |
Xiangyang Shi | 52 | 2018 | Deputy GM & Non Independent Director |
Haiyi Li | 39 | 2022 | Non-Employee Supervisor |
Wuzhen Jiang | 51 | 2019 | Independent Director |
Hong Wang | 47 | 2022 | Supervisor |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review